Quantcast
Last updated on April 17, 2014 at 16:26 EDT

Latest Low-density lipoprotein Stories

GMO Tomatoes Target Intestinal Lipids And Improve Cholesterol
2013-11-14 05:24:10

[ Watch the Video: GMO Tomato Mimics HDL, Lowers Cholesterol ] Brett Smith for redOrbit.com - Your Universe Online A long-overlooked lipid found in the small intestine has a greater role in generating high cholesterol levels and inflammation than previously thought, according to new research published in Journal of Lipid Research. The researchers also discovered that they could lower the negative impact of these lipids in mice by giving the animals a novel, genetically-engineered...

2013-11-13 20:23:50

LOS ANGELES, Nov. 13, 2013 /PRNewswire-USNewswire/ -- UCLA researchers report that tiny amounts of a specific type of lipid in the small intestine may play a greater role than previously thought in generating the high cholesterol levels and inflammation that lead to clogged arteries. The team also found they could reduce the negative effects of these lipids in mice by feeding the animals a new genetically engineered tomato being developed at UCLA that is designed to mimic HDL...

2013-11-13 12:27:06

Company Attributes its 32,031 Percent Revenue Growth to Innovation and Focus FRAMINGHAM, Mass., Nov. 13, 2013 /PRNewswire/ -- Boston Heart Diagnostics Corporation, a pioneer in integrating next-generation diagnostics into personalized nutrition and lifestyle programs for patients with or at risk for heart disease, today announced it ranked eight on Deloitte's Technology Fast 500, a ranking of the 500 fastest growing technology, media, telecommunications, life sciences, and clean...

2013-11-12 08:37:02

First Long-Term Data of a PCSK9 Inhibitor to be Featured in Clinical Science: Special Reports Session THOUSAND OAKS, Calif., Nov. 12, 2013 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that it will present new data on evolocumab (AMG 145), an investigational fully human monoclonal antibody that inhibits PCSK9, a protein that reduces the liver's ability to remove low-density lipoprotein cholesterol (LDL-C), or "bad" cholesterol, from the blood(1), at the upcoming American Heart...

2013-11-08 23:20:23

Containing a blend of health-boosting herbs, NuVitality‘s Pure White Mulberry Supplement naturally lowers blood sugar and blocks cholesterol buildup in arteries. CHICAGO, ILLINOIS (PRWEB) November 08, 2013 Heart disease and diabetes are two of the most prevalent maladies in modern society, and there are many prescription drugs on the market to artificially lower cholesterol and chemically replace sugar in food. Now there is an all-natural White Mulberry Leaf Extract supplement from...

2013-11-01 20:22:39

WOODBRIDGE, ON, Nov. 1, 2013 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CNSX: PVO), a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease (CVD) and overall health, announced today that it has extended the closing date of the previously announced (October 2, 2013 and October 7, 2013) debt financing to November 30(th), 2013. "The financing is progressing well and to date we have received CDN $1.65 Million of the $5.0 Million...

2013-10-17 16:57:00

Researchers find 5-fold increase in high cholesterol risk What leads to high cholesterol? Your genes and lifestyle factors may not explain it all. A study presented today at the Canadian Cardiovascular Congress has connected some of the risk for high cholesterol in adults to their mother's cholesterol levels before she even became pregnant. The key finding: if a mother had high LDL ("bad") cholesterol prior to a pregnancy, her children are almost five times as likely to also have high...

2013-10-17 00:20:49

MONTREAL, Oct. 17, 2013 /CNW/ - Here are summaries of today's press releases featuring research presented today at Vascular 2013 in Montreal. Unlocking a brighter future for Locked-In Syndrome Researchers use technology to help immobilized stroke survivors regain some independence A team of researchers from Montreal has found that stroke patients living with Locked-In Syndrome (LIS) who cannot move, swallow or even breathe on their own, can regain a remarkable level of...

2013-10-16 00:20:44

Alirocumab monotherapy reduced "bad" cholesterol three times more than ezetimibe PARIS and TARRYTOWN, N.Y., Oct. 16, 2013 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the Phase 3 ODYSSEY MONO trial with alirocumab, an investigational monoclonal antibody targeting PCSK9 (proprotein convertase subtilisin/kexin type 9), met its primary efficacy endpoint. The mean low-density lipoprotein-cholesterol (LDL-C,...

2013-10-15 11:59:29

Researchers from the CNIC and the CSIC publish their findings in EMBO Molecular Medicine Researchers of the Spanish research council (Consejo Superior de Investigaciones Científicas, CSIC) and the Centro Nacional de Investigaciones Cardiovasculares (CNIC) have discovered that inhibiting the protein Rcan1 in mice reduces the burden of atherosclerosis, one of the commonest cardiovascular diseases. The results of their study, published in the prestigious journal EMBO Molecular Medicine,...